Cleared Abbreviated

K053381 - WELCH ALLYN CONNEX VITAL SOLUTIONS SOFTWARE

K053381 is an FDA 510(k) clearance for WELCH ALLYN CONNEX VITAL SOLUTIONS SOFTWARE, manufactured by Welch Allyn, Inc.. The device is a Class 2 Anesthesiology device with product code DQA cleared through the Abbreviated 510(k) pathway after a 192-day FDA review.

K053381 · Welch Allyn, Inc. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2006
Decision
192d
Days
Class 2
Risk

K053381 is an FDA 510(k) clearance for the WELCH ALLYN CONNEX VITAL SOLUTIONS SOFTWARE. Classified as Oximeter (product code DQA), Class II - Special Controls.

Submitted by Welch Allyn, Inc. (Skaneateles Falls, US). The FDA issued a Cleared decision on June 15, 2006 after a review of 192 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 870.2700 - the FDA anesthesiology and respiratory device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Welch Allyn, Inc. devices

FDA 510(k) Submission Details - K053381

510(k) Number K053381 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 2005
Decision Date June 15, 2006
Days to Decision 192 days
Submission Type Abbreviated
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
52d slower than avg
Panel avg: 140d · This submission: 192d
Pathway characteristics
Standards-based clearance path.

DQA Device Classification - Class 2, Special Controls

Product Code DQA Oximeter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - DQA Oximeter

All 453
Devices cleared under the same product code (DQA) and FDA review panel - the closest regulatory comparables to K053381.
MASIMO SET RADICAL 7 PULSE CO-OXIMETER
K061204 · Masimo Corporation · Jul 2006
INFINITY MASIMO SET SP02 POD
K061329 · Draeger Medical Systems, Inc. · Jul 2006
LNCS AND SPO2.COM SENSORS
K060143 · Masimo Corporation · Jun 2006
CONMED PRO2 PULSE REFLECTANCE OXIMETER, MODEL PRO-M
K061112 · Conmed Corporation · May 2006
PM-50 PULSE OXIMETER
K052693 · Shenzhen Mindray Bio-Medical Electronics Co., Ltd. · Mar 2006
MASIMO SET RAD 57 CM AND M PULSE CO-OXIMETERS
K053477 · Masimo Corporation · Mar 2006